Cancer-Causing Proteins Concord NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Karis H Kremers, MD
(704) 783-1370
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Ms Sch Of Med, Jackson Ms 39216
Graduation Year: 1980

Data Provided by:
Thomas Albert Steffens, MD
(704) 783-1370
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1982

Data Provided by:
Richard F Williams, MD
(704) 783-3000
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Ar Coll Of Med, Little Rock Ar 72205
Graduation Year: 1988

Data Provided by:
John David Turner, MD
(704) 783-3369
200 Medical Park Dr Ste 145
Concord, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Emory Univ Sch Of Med, Atlanta Ga 30322
Graduation Year: 1992

Data Provided by:
William Robert Mitchell, MD
(704) 593-0244
101 E Wt Harris Blvd Ste 5203
Charlotte, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Univ Of Louisville Sch Of Med, Louisville Ky 40202
Graduation Year: 1990
Hospital
Hospital: Union Mem Hosp, Monroe, Nc
Group Practice: Piedmont Oncology Specialist

Data Provided by:
James Hugh North
(704) 786-1108
200 Medical Park Dr
Concord, NC
Specialty
Surgical Oncology

Data Provided by:
Christine Frances Piller
(704) 783-1542
920 Church St N
Concord, NC
Specialty
Hematology

Data Provided by:
James G Wall
(704) 783-1370
100 Medical Park Dr
Concord, NC
Specialty
Internal Medicine, Hematology / Oncology

Data Provided by:
George Philip Sartiano, MD
Kannapolis, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1960

Data Provided by:
Ronald Dean Butler
(704) 593-0244
101 W. T. Harris Blvd
Charlote, NC
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com